Purchase Order 75N92E20P00182

<p>The National Human Genome Research Institute issued a $30,051.65 delivery order to Illumina, Inc. on May 6, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has an ultimate completion date of September 2, 2020. Pricing is firm fixed price, and no set-aside was used.</p>

This firm fixed-price purchase order awarded by the National Institutes of Health's National Center for Advancing Translational Sciences to Active Motif, Inc. is valued at $405,000. Under the terms of the contract, Active Motif will provide single-nuclei multiome analysis services for 50 samples of human brain tissue, induced pluripotent stem cell-derived cells, or human dorsal root ganglion as requested in Solicitation Number NCATS-23-0414. The solicitation sought these sequencing and data...

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on July 17, 2019, with a ceiling value of $24,014.90 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA 92122. The order has a firm fixed-price structure with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a purchase order to Pacific Biosciences of California, Inc. on October 8, 2020, with a ceiling value of $23,531.00 to perform high-throughput, large-scale DNA sequencing and sequence analysis. Work is performed in Menlo Park, California. The order carries firm fixed-price pricing and has an ultimate completion date of December 8, 2020.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc., on February 27, 2019, with a ceiling value of $31,781.16 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is San Diego, CA. The order was firm fixed-price with no set-aside designation and an ultimate completion date of September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a $98,905.32 delivery order to Illumina, Inc. on August 22, 2019, for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD 20892. The order is firm fixed-price with an ultimate completion date of September 2, 2020. No set-aside was used.</p>

The NIH Clinical Center awarded a purchase order to Active Motif, Inc. for $14,190 on April 21, 2020. The order, firm fixed price with no set-aside, supports genomic research tools and services. Place of performance is Bethesda, Maryland. The order ceiling value of $14,190 reflects a commercial simplified acquisition for laboratory research materials or sequencing services aligned with Active Motif's core offerings in epigenetics and molecular analysis. Ultimate completion was April 20, 2021.

<p>The National Human Genome Research Institute awarded a purchase order to Life Technologies Corporation valued at $17,520.03 on June 6, 2019, with an ultimate completion date of August 8, 2020.</p> <p>Work is performed in Carlsbad, California. The order procures laboratory instrumentation, reagents, and consumables. Pricing is firm fixed price with no set-aside used.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on July 30, 2019, with a ceiling value of $79,168.54 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order was firm fixed price with no set-aside and an ultimate completion date of September 2, 2020.</p>

<p>The National Human Genome Research Institute issued a delivery order to Illumina, Inc. on March 27, 2018, with a ceiling value of $19,253.76 for genetic sequencing and genomic analysis technologies.</p> <p>Place of performance is Bethesda, MD. The order has a firm fixed price and was not issued under a set-aside. Ultimate completion date is September 2, 2020.</p>